Investor updates

Highlights

• Phase 1 is live. TaskMaster.bot is deployed at our UK Trade Retail client on WhatsApp, generating our first confirmed revenue against a GBP 52,000 annual operational loss, with Phase 2 scoping underway.
• The 50/50 GPU inference derivatives joint venture with Capacify Inc. is active. A GBP 125,000 Phase 1 Blueprint is in delivery, and a benchmark partnership proposal has gone to Compute Desk, whose GPU compute price index sits on 350,000 Bloomberg terminals.
• Nine active commercial engagements across nine sectors, all on a fixed Phase 1 fee with no equity dilution.
• Ruby Token is priced at $0.01 with a $0.20 target listing price, a 20x on the current price.

Key metrics

Ruby Token is a utility token. $0.20 is the target Tier 1 listing price, not a current value.

Commentary

The commercial model is live. Phase 1 has deployed at our UK Trade Retail client on TaskMaster.bot, generating our first confirmed revenue against a GBP 52,000 annual operational loss, and Phase 2 scoping is underway. It confirms the model works in the field, not just on paper.

The pipeline is broad and moving. Nine engagements span nine sectors, from institutional finance (the GPU inference derivatives JV with Capacify) to aviation, film, music, healthcare, MedTech, beach commerce and cyber intelligence. Every engagement runs on RubySDK Core, and every on-chain operation drives per-operation Ruby Token demand.

We charge a fixed Phase 1 fee on each engagement, with no equity and no revenue share. That keeps the model clean: we are paid to build, investors are not diluted, and each engagement that goes live adds an independent source of token demand.

What's next

• GPU inference derivatives board paper in July 2026, with the JV progressing toward the manual OTC desk in H2 2026.
• The milestone chain toward the Ruby Token Tier 1 exchange listing at $0.20: a second signed contract to confirm a repeatable model, then listing.